Literature DB >> 4673447

Effects of levodopa in Parkinsonian patients with dementia.

O W Sacks, M S Kohl, C R Messeloff, W F Schwartz.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4673447     DOI: 10.1212/wnl.22.5.516

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  5 in total

1.  Schizophrenia: a theory.

Authors:  E Hartmann
Journal:  Psychopharmacology (Berl)       Date:  1976-08-26       Impact factor: 4.530

2.  Influence of certain factors on the manifestations of the adverse effects of metrizamide myelography.

Authors:  Y L Yu; G H du Boulay; E Paul
Journal:  Neuroradiology       Date:  1986       Impact factor: 2.804

Review 3.  A risk-benefit assessment of drugs used in the management of Parkinson's disease.

Authors:  I Y Bodagh; D R Robertson
Journal:  Drug Saf       Date:  1994-08       Impact factor: 5.606

Review 4.  Hallucinations in Parkinson disease.

Authors:  Nico J Diederich; Gilles Fénelon; Glenn Stebbins; Christopher G Goetz
Journal:  Nat Rev Neurol       Date:  2009-06       Impact factor: 42.937

5.  Suppression of REM rebound by Pergolide.

Authors:  J J Askenasy; M D Yahr
Journal:  J Neural Transm       Date:  1984       Impact factor: 3.575

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.